强生H1业绩报:肿瘤收入破百亿美元,上调全年增长预期

动脉网
18 Jul

强生2025年上半年业绩报告显示,公司全球收入达456.36亿美元,同比增长4.1%。其中,创新药板块贡献了290.75亿美元,同比增长3.6%,医疗科技板块收入165.61亿美元,同比增长5.0%。第二季度,总收入为237.43亿美元,同比增长5.8%。肿瘤业务表现尤为突出,上半年收入达到119.90亿美元,同比增长21.1%,主要得益于Darzalex、Erleada和Imbruvica等产品...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10